Sustainability is the investment for the future and it is at the core of our business.
Jubilant Life Sciences believes that addressing the challenges of the future rests
on the Triple bottom line of Sustainability.

Manufacturing

At Jubilant Life Sciences Limited, we operate with the objective of sustainable growth along with an understanding of optimum utilisation of resources, facilitating creativity, innovation and resource conservation.

We have grown tremendously over the years and our manufacturing facilities are taking strides to provide best in industry products and services through reduced cost of operations, engineering initiatives and capacity de-bottlenecking. We use world class manufacturing techniques and Total Productive Maintenance (TPM) with the help of which our manufacturing facilities have proven to be highly profitable. The technologies used at our facilities are environment friendly and all processes are conducted within well equipped and safe plants.

Presently, we operate from 7 manufacturing plants in India and 4 manufacturing plants at different locations in North America. Our plant for generics is located in the United States at Salisbury, Maryland which is serving as a huge generics market for North America. We are successfully developing numerous product fillings and we wish to expand to other international circuits. Sufficient support is provided by the Roorkee, Uttrakhand, India plant where dosage formulations is manufactured and supplied further to other global locations.

Sterile Injectable plants and OCL manufacturing are at Spokane, Washington, US and Montreal, Quebec, Canada. Both the plants are approved by the US FDA and other major regulatory bodies. Contract Manufacturing Outsourcing (CMO) by our specialists to local competitors has provided our North American contract manufacturing facility with a cutting edge over several others giving us a top 5 ranking in the market.

Our Spokane facility also houses Allergy Therapy Products business, while the Montreal facility in Canada supports our Radiopharmaceuticals business. Keeping our suppliers in mind who provide for raw materials and also to stay within the proximity of the market, we are located ideally in Canada. The entire distribution of manufacturing facilities and research units across the globe is devised in such a manner that proximity to end customers is strategically planned. Our manufacturing facilities are reliable in terms of quality, environment and safety. We have a sustained accreditation of IMS, cGMPa’s as well the approval of US FDA, UK MHRA and PMDA (Japan). The production of API’s and Solid Dosage Formulations in India has taken us to newer heights in a progressive and consistent manner.

Another recent achievement for Jubilant has been the world class facility at Bharuch SEZ, Gujarat where Vitamins, Fine Ingredients are produced in the Life Science Ingredients space. All our units are well equipped with the most modern technology i.e. automated manufacturing plants, quality and QA systems that are in accordance with the international standards.

We believe that in order to run a successful and sustainable business we need to be aware and opt for a proactive approach that is in consensus with the regulatory authorities. With the help of our latest technology and a team that comprises of experts of the industry the manufacturing function has proved to be a breakthrough in the success of our company.